|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Study Type: | Interventional |
|---|---|
| Study Design: | Allocation: Randomized; Endpoint Classification: Safety/Efficacy Study; Intervention Model: Parallel Assignment; Masking: Open Label; Primary Purpose: Treatment |
| Condition: |
Hyponatremia |
| Interventions: |
Drug: Isotonic fluid Drug: Hypotonic fluid |
Participant Flow
| Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations |
|---|
| Enrollment: September 2006 to April 2008 Analysis: May and June 2008 Pediatric ward and Pediatric intensive care unit in a tertiary care referral hospital in North India |
| Significant events and approaches for the overall study following participant enrollment, but prior to group assignment |
|---|
| Patients were stratified based on their age in to three groups (age 3 months to 1 year, 1-5 years, 6-12 years) and stratified randomization was used. |
| Description | |
|---|---|
| Dextrose Normal Saline | Normal saline in 5% dextrose at standard maintenance rate |
| Fluid Restriction Group | Reduced volume (2/3 maintenance rate) of N/5 saline in 5% dextrose |
| Hypotonic Saline | N/5 saline in 5% dextrose at standard maintenance rate |
| Dextrose Normal Saline | Fluid Restriction Group | Hypotonic Saline | |
|---|---|---|---|
| STARTED | 58 | 53 | 56 |
| COMPLETED | 58 | 53 | 56 |
| NOT COMPLETED | 0 | 0 | 0 |
Baseline Characteristics
| Description | |
|---|---|
| Dextrose Normal Saline | Normal saline in 5% dextrose at standard maintenance rate |
| Fluid Restriction Group | Reduced volume (2/3 maintenance rate) of N/5 saline in 5% dextrose |
| Hypotonic Saline | N/5 saline in 5% dextrose at standard maintenance rate |
| Dextrose Normal Saline | Fluid Restriction Group | Hypotonic Saline | Total | |
|---|---|---|---|---|
|
Number of Participants
[units: participants] |
58 | 53 | 56 | 167 |
|
Age
[units: participants] |
||||
| <=18 years | 58 | 53 | 56 | 167 |
| Between 18 and 65 years | 0 | 0 | 0 | 0 |
| >=65 years | 0 | 0 | 0 | 0 |
|
Age
[units: years] Mean ± Standard Deviation |
3 ± 0.44 | 3 ± 0.36 | 4 ± 0.28 | 3.33 ± 0.56 |
|
Gender
[units: participants] |
||||
| Female | 36 | 35 | 43 | 114 |
| Male | 22 | 18 | 13 | 53 |
|
Region of Enrollment
[units: participants] |
||||
| India | 58 | 53 | 56 | 167 |
Outcome Measures
| 1. Primary: | Incidence of Hyponatremia (Defined as Serum Sodium Less Than 130 mmol/L) [ Time Frame: 72 hrs ] |
| 2. Secondary: | Incidence of Hypernatremia (Serum Sodium >150 mmol/L) [ Time Frame: 72 hrs ] |
| 3. Secondary: | Incidence of Symptomatic Hyponatremia [ Time Frame: 72 hrs ] |
| 4. Secondary: | Incidence of Symptomatic Hypernatremia [ Time Frame: 72 hrs ] |
More Information
| All Principal Investigators ARE employed by the organization sponsoring the study. |
| Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data |
|---|
| No text entered. |
| Responsible Party: | Dr Rakesh Lodha, All India Institute of Medical Sciences |
| ClinicalTrials.gov Identifier: | NCT00621348 History of Changes |
| Other Study ID Numbers: | RL-1 |
| Study First Received: | February 12, 2008 |
| Results First Received: | July 12, 2011 |
| Last Updated: | August 8, 2011 |
| Health Authority: | India: Institutional Review Board |